{"filing":{"accession_number":"0001104659-26-068306","cik":"0001649989","ticker":"OTLK","company_name":"Outlook Therapeutics, Inc.","form":"8-K","filing_date":"2026-05-29","report_date":null,"primary_document":"tm2615979d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1649989/000110465926068306/tm2615979d1_8k.htm"},"events":[{"id":8055,"run_id":7070,"accession_number":"0001104659-26-068306","anchor_item_number":"8.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses a registered direct offering of 8,539,709 shares of common stock to GMS Ventures and Investments pursuant to a securities purchase agreement dated May 28, 2026. This is a material equity issuance that dilutes existing shareholders and is typically a signal of capital-raising activity at smaller issuers. The transaction was conducted under an effective Form S-3 registration statement, making it a registered offering rather than an unregistered private placement, but it remains a material dilutive issuance requiring disclosure.","company_name":"Outlook Therapeutics, Inc.","ticker":"OTLK","filing_date":"2026-05-29","form":"8-K","submitted_at":null,"items":[{"id":2620,"accession_number":"0001104659-26-068306","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses a registered direct offering of 8,539,709 shares of common stock to GMS Ventures and Investments pursuant to a securities purchase agreement dated May 28, 2026. This is a material equity issuance that dilutes existing shareholders and is typically a signal of capital-raising activity at smaller issuers. The transaction was conducted under an effective Form S-3 registration statement, making it a registered offering rather than an unregistered private placement, but it remains a material dilutive issuance requiring disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:07:23.792218+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":2620,"accession_number":"0001104659-26-068306","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses a registered direct offering of 8,539,709 shares of common stock to GMS Ventures and Investments pursuant to a securities purchase agreement dated May 28, 2026. This is a material equity issuance that dilutes existing shareholders and is typically a signal of capital-raising activity at smaller issuers. The transaction was conducted under an effective Form S-3 registration statement, making it a registered offering rather than an unregistered private placement, but it remains a material dilutive issuance requiring disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:07:23.792218+00:00","company_name":"Outlook Therapeutics, Inc.","ticker":"OTLK","filing_date":"2026-05-29"}]}